Cargando…
QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo
QiLing Decoction (QLD) showed therapeutic effects against prostate cancer with an unclear underlying mechanism. This study explored the underlying mechanisms of QLD against castration-resistant prostate cancer (CRPC). Clinical specimens were collected from the patients with CRPC. Stable cells includ...
Autores principales: | Cao, Hongwen, Wu, Xiaotong, Gao, Renjie, Chen, Lei, Feng, Yigeng, Wang, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414048/ https://www.ncbi.nlm.nih.gov/pubmed/37576395 http://dx.doi.org/10.7150/jca.84363 |
Ejemplares similares
-
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
por: Cao, Hongwen, et al.
Publicado: (2022) -
Qi Ling decoction enhances abiraterone treatment via suppression of autophagy in castration resistant prostate cancer
por: Feng, Yigeng, et al.
Publicado: (2022) -
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis
por: Cao, Hongwen, et al.
Publicado: (2021) -
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway
por: Cao, Hongwen, et al.
Publicado: (2023) -
Zhoushi Qiling decoction induces apoptosis of human prostate cancer cells via miR-143/Bcl-2 axis
por: Cao, Hongwen, et al.
Publicado: (2021)